Bültmann & Gerriets
The Biology of the Schizophrenic Process
von Stewart Wolf
Verlag: Springer US
Reihe: Advances in Behavioral Biology Nr. 19
Hardcover
ISBN: 978-1-4615-8995-2
Auflage: Softcover reprint of the original 1st ed. 1976
Erschienen am 25.11.2012
Sprache: Englisch
Format: 244 mm [H] x 170 mm [B] x 12 mm [T]
Gewicht: 375 Gramm
Umfang: 212 Seiten

Preis: 53,49 €
keine Versandkosten (Inland)


Dieser Titel wird erst bei Bestellung gedruckt. Eintreffen bei uns daher ca. am 22. Oktober.

Der Versand innerhalb der Stadt erfolgt in Regel am gleichen Tag.
Der Versand nach außerhalb dauert mit Post/DHL meistens 1-2 Tage.

53,49 €
merken
zum E-Book (PDF) 53,49 €
klimaneutral
Der Verlag produziert nach eigener Angabe noch nicht klimaneutral bzw. kompensiert die CO2-Emissionen aus der Produktion nicht. Daher übernehmen wir diese Kompensation durch finanzielle Förderung entsprechender Projekte. Mehr Details finden Sie in unserer Klimabilanz.
Klappentext
Inhaltsverzeichnis

This volume contains the edited transcript of the second Totts Gap Colloquium, held at Totts Gap, Pennsylvania, May 29-31, 1975. The objective of the Colloquium was to bring into focus what is known of pathogenic mechanisms of schizophrenic manifestations. One hope was to differentiate among syndromes that share the fea~ tures of schizophrenia, disorganization of thought and talk, inap­ propriateness of affect, circumstantiality, withdrawal from social interaction, paranoid ideation, hallucinations, delusions, catelepsy, catatonic excitement or mutism, etc. What is known of the neural and chemical processes capable of inducing such aberrations was discussed with an attempt to reconcile disparate findings and in­ terpretations, to synthesize current evidence and to point up cru­ cial areas of ignorance that need exploration. The program was designed to further the objectives of the Multidisciplinary Research Program in Mental Health, of the University of Texas Medical Branch and to supplement their efforts with a well focused look at the schizophrenic process. Accordingly, Dr. Allan Goldstein, Professor of Biochemistry and Acting Director of the Multidisciplinary Re­ search Program in Mental Health; Dr. Bernard Haber, Associate Pro­ fessor of Biochemistry and Member of the Marine Biomedical Institute; and Dr. Geraldine Cohen, Assistant Professor, Department of Human Biological Chemistry and Genetics, joined in discussion with the Colloquium participants who were as follows: Dr. Mark D. Altschule, Clinical Professor, Harvard Medical School. Dr. Llewellyn B. Bigelow, Director of ~ental Health Research, St. Elizabeth's Hospital. Dr. Eugene L. Bliss, Professor and Chairman of Psychiatry, University of Utah.



I Historical Perspective - Evolution of the Concept of Schizophrenia.- II The Nature of Schizophrenia.- III Neural Substrates.- IV The Genetics of Schizophrenia.- V Pathophysiology - Biochemical Considerations.- VI Clinical Investigations.- VII Etiological Considerations..- VIII Therapy.- IX Synthesis.- Name Index.


andere Formate
weitere Titel der Reihe